Abstract
Importance
Machine learning (ML) algorithms have the potential to identify eyes with early diabetic retinopathy (DR) at increased risk for disease progression.Objective
To create and validate automated ML models (autoML) for DR progression from ultra-widefield (UWF) retinal images.Design, setting and participants
Deidentified UWF images with mild or moderate nonproliferative DR (NPDR) with 3 years of longitudinal follow-up retinal imaging or evidence of progression within 3 years were used to develop automated ML models for predicting DR progression in UWF images. All images were collected from a tertiary diabetes-specific medical center retinal image dataset. Data were collected from July to September 2022.Exposure
Automated ML models were generated from baseline on-axis 200° UWF retinal images. Baseline retinal images were labeled for progression based on centralized reading center evaluation of baseline and follow-up images according to the clinical Early Treatment Diabetic Retinopathy Study severity scale. Images for model development were split 8-1-1 for training, optimization, and testing to detect 1 or more steps of DR progression. Validation was performed using a 328-image set from the same patient population not used in model development.Main outcomes and measures
Area under the precision-recall curve (AUPRC), sensitivity, specificity, and accuracy.Results
A total of 1179 deidentified UWF images with mild (380 [32.2%]) or moderate (799 [67.8%]) NPDR were included. DR progression was present in half of the training set (590 of 1179 [50.0%]). The model's AUPRC was 0.717 for baseline mild NPDR and 0.863 for moderate NPDR. On the validation set for eyes with mild NPDR, sensitivity was 0.72 (95% CI, 0.57-0.83), specificity was 0.63 (95% CI, 0.57-0.69), prevalence was 0.15 (95% CI, 0.12-0.20), and accuracy was 64.3%; for eyes with moderate NPDR, sensitivity was 0.80 (95% CI, 0.70-0.87), specificity was 0.72 (95% CI, 0.66-0.76), prevalence was 0.22 (95% CI, 0.19-0.27), and accuracy was 73.8%. In the validation set, 6 of 9 eyes (75%) with mild NPDR and 35 of 41 eyes (85%) with moderate NPDR progressed 2 steps or more were identified. All 4 eyes with mild NPDR that progressed within 6 months and 1 year were identified, and 8 of 9 (89%) and 17 of 20 (85%) with moderate NPDR that progressed within 6 months and 1 year, respectively, were identified.Conclusions and relevance
This study demonstrates the accuracy and feasibility of automated ML models for identifying DR progression developed using UWF images, especially for prediction of 2-step or greater DR progression within 1 year. Potentially, the use of ML algorithms may refine the risk of disease progression and identify those at highest short-term risk, thus reducing costs and improving vision-related outcomes.References
Articles referenced by this article (11)
Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
JAMA Netw Open, (3):e220269 2022
MED: 35289862
Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity.
Ophthalmology, (12):2587-2595 2013
MED: 23778092
Applications of Artificial Intelligence to Electronic Health Record Data in Ophthalmology.
Transl Vis Sci Technol, (2):13 2020
MED: 32704419
Deep learning algorithm predicts diabetic retinopathy progression in individual patients.
NPJ Digit Med, 92 2019
MED: 31552296
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
N Engl J Med, (16):1507-1516 2017
MED: 28423305
Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years.
Ophthalmology, (5):949-956 2015
MED: 25704318
Automated deep learning design for medical image classification by health-care professionals with no coding experience: a feasibility study.
Lancet Digit Health, (5):e232-e242 2019
MED: 33323271
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Ophthalmology, (5 Suppl):823-833 1991
MED: 2062515
Predicting the risk of developing diabetic retinopathy using deep learning.
Lancet Digit Health, (1):e10-e19 2020
MED: 33735063
Sample-Size Determination Methodologies for Machine Learning in Medical Imaging Research: A Systematic Review.
Can Assoc Radiol J, (4):344-353 2019
MED: 31522841
Show 1 more reference (10 of 11)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/159291114
Article citations
Trends and hotspots in the field of diabetic retinopathy imaging research from 2000-2023.
Front Med (Lausanne), 11:1481088, 09 Oct 2024
Cited by: 0 articles | PMID: 39444814 | PMCID: PMC11496202
Review Free full text in Europe PMC
Novel artificial intelligence for diabetic retinopathy and diabetic macular edema: what is new in 2024?
Curr Opin Ophthalmol, 35(6):472-479, 09 Sep 2024
Cited by: 0 articles | PMID: 39259647 | PMCID: PMC11426980
Review Free full text in Europe PMC
Modern Approach to Diabetic Retinopathy Diagnostics.
Diagnostics (Basel), 14(17):1846, 24 Aug 2024
Cited by: 0 articles | PMID: 39272631 | PMCID: PMC11394437
Review Free full text in Europe PMC
Diabetic retinopathy identification based on multi-source-free domain adaptation.
Int J Ophthalmol, 17(7):1193-1204, 18 Jul 2024
Cited by: 0 articles | PMID: 39026925 | PMCID: PMC11246935
Error in Abstract, Key Points, and Results.
JAMA Ophthalmol, 142(6):588, 01 Jun 2024
Cited by: 0 articles | PMID: 38573596 | PMCID: PMC11190799
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Performance of Automated Machine Learning for Diabetic Retinopathy Image Classification from Multi-field Handheld Retinal Images.
Ophthalmol Retina, 7(8):703-712, 15 Mar 2023
Cited by: 6 articles | PMID: 36924893
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.
JAMA Ophthalmol, 140(10):946-954, 01 Oct 2022
Cited by: 23 articles | PMID: 35980608 | PMCID: PMC9389433
Comparison of Widefield Laser Ophthalmoscopy and ETDRS Retinal Area for Diabetic Retinopathy.
Ophthalmol Sci, 2(4):100190, 28 Jun 2022
Cited by: 2 articles | PMID: 36531579 | PMCID: PMC9754965
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Cochrane Database Syst Rev, 2:CD013775, 22 Feb 2023
Cited by: 29 articles | PMID: 36815723 | PMCID: PMC9943918
Review Free full text in Europe PMC
Funding
Funders who supported this work.
Medical Research Council (1)
The UK-Philippines Remote Retinal Evaluation Collaboration in Health: Diabetic Retinopathy (REACH-DR)
Professor Tunde Peto, Queen's University of Belfast
Grant ID: MR/R025630/1